-
Loading metrics
Open Access
Peer-reviewed
Research Article
Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children
-
Mark R Withers ,
*To whom correspondence should be addressed. E-mail: mwithers@us.army.mil
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Denise McKinney,
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Bernhards R Ogutu,
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
John N Waitumbi,
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Jessica B Milman,
Affiliation The Bill and Melinda Gates Foundation, Seattle, Washington, United States of America
⨯ -
Odika J Apollo,
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Otieno G Allen,
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Kathryn Tucker,
Affiliation Statistics Collaborative, Washington, District of Columbia, United States of America
⨯ -
Lorraine A Soisson,
Affiliation Malaria Vaccine Development Program, United States Agency for International Development, Washington, District of Columbia, United States of America
⨯ -
Carter Diggs,
Affiliation Malaria Vaccine Development Program, United States Agency for International Development, Washington, District of Columbia, United States of America
⨯ -
Amanda Leach,
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
⨯ -
Janet Wittes,
Affiliation Statistics Collaborative, Washington, District of Columbia, United States of America
⨯ -
Filip Dubovsky,
Affiliation MedImmune, Gaithersburg, Maryland, United States of America
⨯ -
V. Ann Stewart,
Affiliation Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Shon A Remich,
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Joe Cohen,
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
⨯ -
W. Ripley Ballou,
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
⨯ -
Carolyn A Holland,
Affiliation Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Jeffrey A Lyon,
Affiliation Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Evelina Angov,
Affiliation Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
José A Stoute,
Affiliation Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Samuel K Martin,
Affiliations United States Army Medical Research Unit–Kenya, Nairobi, Kenya, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
D. Gray Heppner Jr.,
Affiliation Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ - [ ... ],
- for the MSP-1 Malaria Vaccine Working Group
- [ view all ]
- [ view less ]
Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children
- Mark R Withers,
- Denise McKinney,
- Bernhards R Ogutu,
- John N Waitumbi,
- Jessica B Milman,
- Odika J Apollo,
- Otieno G Allen,
- Kathryn Tucker,
- Lorraine A Soisson,
- Carter Diggs
- Published: November 24, 2006
- https://doi.org/10.1371/journal.pctr.0010032